| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0005 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.003 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |